Cefixime trihydrate
Cefixime trihydrate structure
|
Common Name | Cefixime trihydrate | ||
|---|---|---|---|---|
| CAS Number | 125110-14-7 | Molecular Weight | 507.495 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C16H21N5O10S2 | Melting Point | 218-225℃ | |
| MSDS | Chinese USA | Flash Point | N/A | |
| Symbol |
GHS08 |
Signal Word | Danger | |
Use of Cefixime trihydrateCefixime trihydrate (FR-17027 trihydrate) is an antibiotic and a third generation cephalosporin antibiotic, useful for the treatment of a number of bacterial infections[1][2]. |
| Name | Ytterbium(III) ionophore I,Cefixime trihydrate |
|---|---|
| Synonym | More Synonyms |
| Description | Cefixime trihydrate (FR-17027 trihydrate) is an antibiotic and a third generation cephalosporin antibiotic, useful for the treatment of a number of bacterial infections[1][2]. |
|---|---|
| Related Catalog | |
| References |
| Melting Point | 218-225℃ |
|---|---|
| Molecular Formula | C16H21N5O10S2 |
| Molecular Weight | 507.495 |
| Exact Mass | 507.072968 |
| PSA | 265.74000 |
| LogP | 0.17230 |
|
In vitro antibacterial activity of AZD0914, a new spiropyrimidinetrione DNA gyrase/topoisomerase inhibitor with potent activity against Gram-positive, fastidious Gram-Negative, and atypical bacteria.
Antimicrob. Agents Chemother. 59(1) , 467-74, (2014) AZD0914 is a new spiropyrimidinetrione bacterial DNA gyrase/topoisomerase inhibitor with potent in vitro antibacterial activity against key Gram-positive (Staphylococcus aureus, Staphylococcus epiderm... |
|
|
Characterization of urinary tract infection-associated Shiga toxin-producing Escherichia coli.
Infect. Immun. 82(11) , 4631-42, (2014) Enterohemorrhagic Escherichia coli (EHEC), a subgroup of Shiga toxin (Stx)-producing E. coli (STEC), is a leading cause of diarrhea and hemolytic-uremic syndrome (HUS) in humans. However, urinary trac... |
|
|
The characterization and antibiotic resistance profiles of clinical Escherichia coli O25b-B2-ST131 isolates in Kuwait.
BMC Microbiol. 14 , 214, (2014) Escherichia coli O25b-B2-ST131 are considered virulent extra-intestinal pathogens causing serious clinical complications such as urinary tract infection and bacteraemia. Our main objectives in this st... |
| (6R,7R)-7-({(2Z)-2-(2-Amino-1,3-thiazol-4-yl)-2-[(carboxymethoxy)imino]acetyl}amino)-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid trihydrate |
| CEFIXIME TRIHYDRATE |
| 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2Z)-2-(2-amino-4-thiazolyl)-2-[(carboxymethoxy)imino]-1-oxoethyl]amino]-3-ethenyl-8-oxo-, (6R,7R)-, hydrate (1:3) |